Filtration plasmapheresis in vivo

Area of Science:

• Biomedical Engineering
• Hematology
• Blood Component Technology

Background:

• Conventional plasmapheresis methods can be time-consuming and resource-intensive.
• There is a need for efficient and safe alternatives for plasma collection from blood donors.

Purpose of the Study:

• To develop and evaluate a continuous-flow filtration plasmapheresis system.
• To assess the safety, efficiency, and plasma quality of the new system.

Main Methods:

• The study involved testing a continuous-flow filtration plasmapheresis system in two stages: nonreinfusion and continuous reinfusion.
• Key parameters evaluated included donor safety, separation efficiency, and plasma quality.

Main Results:

• The membrane plasmapheresis system demonstrated feasibility in blood donor applications.
• The system proved to be safe for donors during the testing phases.
• Sufficient plasma yield was achieved for therapeutic or component therapy.

Conclusions:

• Continuous-flow filtration plasmapheresis is a viable and safe alternative to conventional techniques.
• The developed system effectively collects plasma suitable for clinical applications.
• This technology has the potential to improve plasma collection processes for blood donation.